Crestor and Retinal vessel occlusion - a phase IV clinical study of FDA data

Summary:

Retinal vessel occlusion is reported as a side effect among people who take Crestor (rosuvastatin calcium), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Aspirin, and have High blood pressure.

The phase IV clinical study analyzes which people have Retinal vessel occlusion when taking Crestor. It is created by eHealthMe based on reports of 143,349 people who have side effects when taking Crestor from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

What is Retinal vessel occlusion?

Retinal vessel occlusion (a blockage in one of the small arteries) is found to be associated with 468 drugs and 830 conditions by eHealthMe. Check the latest studies of Retinal vessel occlusion.

On Jul, 14, 2026

143,349 people reported to have side effects when taking Crestor.
Among them, 57 people (0.04%) have Retinal vessel occlusion.

Could Crestor cause Retinal vessel occlusion?

Among these 57 people:

How long have people been on Crestor when they have Retinal vessel occlusion? *

What is the gender of people who have Retinal vessel occlusion when taking Crestor? *

female: 50.94 %
male: 49.06 %

What is the age of people who have Retinal vessel occlusion when taking Crestor? *

What are other drugs people take besides Crestor? *

What are other side effects people have besides Retinal vessel occlusion? *

Blindness Unilateral: 15 people, 26.32%
Retinal Haemorrhage (bleeding from retina): 7 people, 12.28%
Visual Acuity Reduced (reduced clearness of vision): 7 people, 12.28%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 7 people, 12.28%
Blindness: 6 people, 10.53%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 10.53%
Visual Impairment: 5 people, 8.77%
Cataract (clouding of the lens inside the eye): 5 people, 8.77%
Eye Haemorrhage (bleeding in the eye): 4 people, 7.02%
Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 4 people, 7.02%

What are the existing conditions these people have? *

High Blood Pressure: 14 people, 24.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.53%
Breast Cancer: 5 people, 8.77%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 7.02%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 7.02%
Seasonal Allergy (allergic condition due to certain season): 4 people, 7.02%
Muscle Spasms (muscle contraction): 3 people, 5.26%
Diabetes: 3 people, 5.26%
Constipation: 3 people, 5.26%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and have Retinal vessel occlusion?

- Check whether Retinal vessel occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crestor:

Crestor (149,761 reports)

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (468 drugs)

Browse all the conditions that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (830 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Crestor) and Crestor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.